共 138 条
[1]
Akhondzadeh S(2001)The 5-HT hypothesis of schizophrenia Idrugs 4 295-300
[2]
Akhondzadeh S(1999)Cyproheptadine in treatment of chronic schizophrenia:a double-blind, placebo-controlled study J Clin Pharm Ther 24 49-52
[3]
Mohammadi MR(2013)World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects JAMA 310 2191-2194
[4]
Amini-Nooshabadi H(2014)The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue Front Psychiatry 5 47-265
[5]
Davari-Ashtiani R(2005)Manual for the extrapyramidal symptom rating scale (ESRS) Schizophr Res 76 247-150
[6]
Association WM(2022)Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 The Lancet Psychiatry 9 137-94
[7]
Brisch R(2019)Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson’s disease therapeutics Neurochem Int 129 104478-899
[8]
Saniotis A(2015)Structured clinical interview for DSM-5—research version (SCID-5 for DSM-5, research version; SCID-5-RV) Arlington, VA: Am Psychiatric Ass 2015 1-62
[9]
Wolf R(2015)Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials Schizophr Bull 41 892-619
[10]
Bielau H(1960)A rating scale for depression J Neurol Neurosurg Psychiatry 23 56-64